Skip to content
The Nexus
DossierENTITY

Zoloft

Coverage of Zoloft in the Nexus archive.

Earliest in view: May 5 · 13:12 UTCMost recent: Aug 17 · 09:00 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHAug 17 · 09:00 UTCWHYY
    I took antidepressants for more than 25 years. Getting off them was harder than I ever imagined.

    The author spent over two decades taking various antidepressants due to feelings of sadness and loneliness, eventually undergoing a difficult tapering process that resulted in severe symptoms like crying, insomnia, dizziness, and a racing heart. To manage withdrawal, she found information related to "The Maudsley Deprescribing Guidelines."

  • HEALTHJul 30 · 19:49 UTCTHE ATLANTIC
    The Real Antidepressant Crisis

    Robert F. Kennedy Jr. criticizes the overprescription of antidepressants, advocating for de-prescribing SSRIs despite patient concerns about their benefits. The article discusses the debate around their effectiveness for moderate-to-severe depression versus everyday distress, noting 17% of American adults use antidepressants.

  • HEALTHJun 5 · 05:59 UTCDEUTSCHE WELLE
    SSRI antidepressants are often 'carelessly prescribed'

    SSRIs, including Prozac and Zoloft, are among the most-prescribed psychiatric drugs. While they help many people, some experts argue they are overprescribed.

  • HEALTHMay 5 · 19:32 UTCARS TECHNICA
    RFK Jr. plans to curb antidepressants, which he falsely compares to heroin

    Robert F. Kennedy Jr. announced plans to curb prescribing of antidepressants, which he falsely compared to heroin, at a Make America Healthy Again Institute event. Mental health experts have condemned his rhetoric and are pushing back on his new efforts. The event focused on 'overmedicalization' and claims that SSRIs are prescribed without informed consent and can be harmful.

  • HEALTHMay 5 · 13:12 UTCSTAT NEWS
    STAT+: Pharmalittle: We’re reading about RFK Jr. targeting antidepressants, J&J pushing an IBD drug, and more

    US Health and Human Services Secretary Robert F. Kennedy Jr. has announced initiatives to reduce the prescription of selective serotonin reuptake inhibitors, a class of antidepressants. Johnson & Johnson is advancing a therapy for inflammatory bowel disease into late-stage testing despite initial results not showing statistically meaningful improvement. The initiatives aim to help patients get off medications and consider non-pharmaceutical interventions.